testosterone
NDC 45802-366, testosterone, gel, from Padagis Israel Pharmaceuticals Ltd.
- Product NDC
- 45802-366
- Status
- Listed
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Dosage form
- GEL
- Route
- TOPICAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205781
- DEA schedule
- CIII
curl https://api.healthcare.dev/v1/drugs/ndc/45802-366 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TESTOSTERONE40.5 mg/2.5g
Pharmacologic classes
Androgen Receptor Agonists [MoA]; Androgen [EPC]; Androstanes [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 45802-366-65 | 45802036665 | 30 PACKET in 1 CARTON (45802-366-65) / 2.5 g in 1 PACKET (45802-366-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/54fcdcb9-fb0e-4164-9e51-f2a5feae3217NADAC price for package 45802036665
GET /v1/drugs/nadac/45802036665
Use it
Look up 45802-366 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/45802-366 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 45802-366. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.